GDR

GENEDRIVE PLC ORD 1.5P

TitleTime
Second Price Monitoring ExtnFri 22/05/20 | 11:05
Price Monitoring ExtensionFri 22/05/20 | 11:00
Second Price Monitoring ExtnFri 22/05/20 | 09:05
Price Monitoring ExtensionFri 22/05/20 | 09:00
Genedrive 96 SARS-CoV-2 Kit receives CE-IVD MarkFri 22/05/20 | 07:00
Holding(s) in CompanyThu 21/05/20 | 09:36
Holding(s) in CompanyWed 20/05/20 | 15:38
Holding(s) in CompanyWed 13/05/20 | 10:26
Results of Broker OptionTue 12/05/20 | 07:00
Holding(s) in CompanyThu 07/05/20 | 17:25
Posting of shareholder circularThu 07/05/20 | 16:58
Second Price Monitoring ExtnThu 07/05/20 | 11:05
Price Monitoring ExtensionThu 07/05/20 | 11:00
Result of PlacingTue 05/05/20 | 18:24
Price Monitoring ExtensionTue 05/05/20 | 09:00
Proposed Placing and Broker OptionTue 05/05/20 | 08:50
WHO Prequalification for Genedrive HCV-ID testMon 04/05/20 | 17:00
Second Price Monitoring ExtnMon 04/05/20 | 14:05
Price Monitoring ExtensionMon 04/05/20 | 14:00
Second Price Monitoring ExtnFri 01/05/20 | 14:05
Price Monitoring ExtensionFri 01/05/20 | 14:01
Manufacturing milestones met for SARS-CoV-2 testFri 01/05/20 | 07:00
Second Price Monitoring ExtnWed 29/04/20 | 09:06
Price Monitoring ExtensionWed 29/04/20 | 09:00
Second Price Monitoring ExtnTue 28/04/20 | 16:42
Price Monitoring ExtensionTue 28/04/20 | 16:35
Second Price Monitoring ExtnTue 28/04/20 | 14:05
Price Monitoring ExtensionTue 28/04/20 | 14:00
Price Monitoring ExtensionMon 27/04/20 | 09:00
Holding(s) in CompanyFri 24/04/20 | 15:30
Distribution agreement for AIHL testFri 24/04/20 | 07:00
Distribution agreement for AIHL testFri 24/04/20 | 07:00
Appointment of Joint BrokerWed 22/04/20 | 07:00
Second Price Monitoring ExtnTue 21/04/20 | 16:41
Price Monitoring ExtensionTue 21/04/20 | 16:36
Holding(s) in CompanyTue 21/04/20 | 14:52
Second Price Monitoring ExtnMon 20/04/20 | 09:05
Price Monitoring ExtensionMon 20/04/20 | 09:00
Cytiva collaboration on Coronavirus PCR TestMon 20/04/20 | 07:00
Second Price Monitoring ExtnFri 17/04/20 | 14:06
Price Monitoring ExtensionFri 17/04/20 | 14:01
Holding(s) in CompanyThu 16/04/20 | 14:53
Second Price Monitoring ExtnWed 15/04/20 | 16:41
Price Monitoring ExtensionWed 15/04/20 | 16:36
Second Price Monitoring ExtnWed 15/04/20 | 14:05
Price Monitoring ExtensionWed 15/04/20 | 14:00
Second Price Monitoring ExtnWed 15/04/20 | 11:05
Price Monitoring ExtensionWed 15/04/20 | 11:00
Second Price Monitoring ExtnTue 14/04/20 | 09:06
Price Monitoring ExtensionTue 14/04/20 | 09:00
Holding(s) in CompanyTue 14/04/20 | 07:01
Holding(s) in CompanyTue 14/04/20 | 07:00
Holding(s) in CompanyTue 31/03/20 | 11:52
Holding(s) in CompanyMon 30/03/20 | 14:01
Second Price Monitoring ExtnMon 30/03/20 | 11:06
Price Monitoring ExtensionMon 30/03/20 | 11:00
Business Update and SARS-COV-2 tests developmentWed 25/03/20 | 07:00
Grant of optionsWed 04/03/20 | 15:33
Holding(s) in CompanyThu 13/02/20 | 09:53
Director/PDMR ShareholdingTue 11/02/20 | 16:00
Holding(s) in CompanyThu 06/02/20 | 16:30
Director/PDMR ShareholdingWed 05/02/20 | 17:38
Director/PDMR ShareholdingWed 05/02/20 | 17:32
Holding(s) in CompanyWed 05/02/20 | 16:45
Director/PDMR ShareholdingTue 04/02/20 | 16:25
Second Price Monitoring ExtnTue 04/02/20 | 14:06
Price Monitoring ExtensionTue 04/02/20 | 14:00
Half-year ReportTue 04/02/20 | 07:00
Notice of ResultsWed 15/01/20 | 07:00
Holding(s) in CompanyWed 11/12/19 | 17:24
Holding(s) in CompanyWed 11/12/19 | 10:06
Additional ListingThu 05/12/19 | 11:30
Result of AGMWed 27/11/19 | 16:23
Director/PDMR ShareholdingFri 22/11/19 | 14:41
Antibiotic Induced Hearing Loss Assay CE markingMon 18/11/19 | 07:00
Notice of AGM and Change of AuditorsWed 06/11/19 | 07:00
Holding(s) in CompanyTue 22/10/19 | 15:07
Holding(s) in CompanyTue 22/10/19 | 15:06
Final ResultsThu 03/10/19 | 07:00
Notice of ResultsMon 09/09/19 | 07:00
Director/PDMR ShareholdingThu 18/07/19 | 07:00
Trading UpdateTue 09/07/19 | 07:00
Director/PDMR ShareholdingFri 05/04/19 | 08:29
Half-year ReportThu 28/03/19 | 07:00
Holding(s) in CompanyWed 16/01/19 | 13:21
Trading updateTue 15/01/19 | 07:00
Result of AGMMon 31/12/18 | 11:30
Holding(s) in CompanyWed 12/12/18 | 07:49
Holding(s) in CompanyMon 10/12/18 | 16:44
Holding(s) in CompanyMon 10/12/18 | 15:40
Holding(s) in CompanyMon 10/12/18 | 11:04
2018 Annual Report and AGM NoticeFri 07/12/18 | 15:07
Result of GMFri 07/12/18 | 14:59
Posting of Shareholder CircularMon 19/11/18 | 15:27
Result of Equity PlacingFri 16/11/18 | 13:42
Unaudited Preliminary ResultsFri 16/11/18 | 07:00
Proposed Placing and Broker OptionFri 16/11/18 | 07:00
Director/PDMR ShareholdingMon 10/09/18 | 13:46
Notice of GMFri 24/08/18 | 07:00
Board AppointmentWed 22/08/18 | 07:00
Director/PDMR ShareholdingThu 19/07/18 | 07:00
Trading UpdateFri 13/07/18 | 07:00
Total Voting RightsFri 29/06/18 | 09:36
Grant for NHS point-of-care testWed 20/06/18 | 07:00
Additional Listing of SharesTue 19/06/18 | 11:18
Completion of DisposalMon 11/06/18 | 09:25
Result of General MeetingMon 04/06/18 | 16:47
Circular re Proposed DisposalThu 17/05/18 | 14:32
Proposed disposal for up to £1.9 million in cashMon 14/05/18 | 17:39
Holding(s) in CompanyThu 10/05/18 | 11:39
Directorate ChangeMon 09/04/18 | 09:06
Director/PDMR ShareholdingWed 04/04/18 | 08:48
genedrive signs distribution agreement for IndiaTue 27/03/18 | 07:00
Holding(s) in CompanyTue 20/03/18 | 15:40
Interim ResultsTue 20/03/18 | 07:00
genedrive Receives Funding for TB Test DevelopmentTue 27/02/18 | 07:00
Notice of ResultsWed 14/02/18 | 07:00
Holding(s) in CompanyWed 17/01/18 | 14:01
Trading updateWed 17/01/18 | 07:00
Director/PDMR ShareholdingThu 07/12/17 | 16:28
Result of AGMWed 29/11/17 | 14:19
genedrive plc awarded Innovate UK grantTue 21/11/17 | 07:00
2017 Annual Report and AGM NoticeFri 17/11/17 | 11:25
Distribution agreement with Sysmex Asia PacificTue 14/11/17 | 07:00
Directorate ChangeWed 08/11/17 | 13:31
Holding(s) in CompanyMon 06/11/17 | 08:51
Distribution update for IndiaThu 02/11/17 | 07:00
Holding(s) in CompanyWed 18/10/17 | 07:00
Preliminary ResultsTue 17/10/17 | 07:00
Distribution AgreementMon 16/10/17 | 07:00
Notice of Preliminary ResultsWed 11/10/17 | 07:00
Holding(s) in CompanyFri 22/09/17 | 09:42
Genedrive HCV Kit received CE MarkingMon 11/09/17 | 07:00
$1.4m Funding from US Department of DefenseThu 27/07/17 | 07:00
Trading UpdateThu 13/07/17 | 07:00